Agenus Inc. (AGEN) Stock Grade

About Agenus Inc.'s fundamentals

Agenus is a small-cap biotechnology company with a market capitalization of $93.4 million that is currently unprofitable, evidenced by a net margin of just 0.1% and an extremely elevated P/E ratio of 811.9. The company has generated revenue growth of 10.4% year-over-year, suggesting some commercial traction in its business operations. With no dividend yield and negative or undefined return on equity, the company is reinvesting any earnings into development rather than returning capital to shareholders. Investors are essentially valuing this biotech firm on its pipeline potential and future prospects rather than current profitability.